-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIEF-Hutchmed (China) Says FDA Orphan Drug Designation For Sovleplenib In Primary Immune Thrombocytopenia

Reuters·10/29/2026 01:29:16

Please log in to view news